Evaluating prevalence and consequence of residual disease in individuals with psoriasis receiving apremilast treatment: results from a US patient survey-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating prevalence and consequence of residual disease in individuals with psoriasis receiving apremilast treatment: results from a US patient survey

Published:2024-06-24 Issue:1 Volume:35 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Bhutani Tina¹,Jayade Sayeli²,Rege Sanika²^ORCID,Penton Hannah³,Patel Vardhaman⁴^ORCID,Kalirai Samaneh⁴,Wolin Daniel⁵,Boyle Kimberly⁵^ORCID,Seigel Lauren⁴^ORCID

Affiliation:

1. Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA, USA

2. OPEN Health Evidence & Access, Hingham, MA, USA

3. OPEN Health Evidence & Access, Rotterdam, The Netherlands

4. Research and Development, Bristol Myers Squibb, Princeton, NJ, USA

5. RTI Health Solutions, Research Triangle Park, NC, USA

Funder

Bristol Myers Squibb

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2024.2366532

Reference24 articles.

1. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

2. Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011

3. Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review

4. Cardiovascular Risk in Patients With Psoriasis

5. Immunology of Psoriasis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP